Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1127-1138

  Selander, Katri S ^a   Mönkkönen, Jukka ^b   Karhukorpi, Eeva Kaisa ^a   Härkönen, Pirkko ^c   Hannuniemi, Ritva ^e   Väänänen, H Kalervo ^a,d  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d Oy Leiras Finland Ab   (Finland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ACID PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; HOMOCYSTEINE; PAMIDRONIC ACID; PROTEIN BCL 2; PROTEIN KINASE C; STAUROSPORINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOCLAST; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

ACID PHOSPHATASE; ANALGESICS, NON-NARCOTIC; ANIMALS; APOPTOSIS; BISBENZIMIDE; CELLS, CULTURED; CLODRONIC ACID; DIPHOSPHONATES; FLUORESCENT DYES; ISOENZYMES; LIPOSOMES; MACROPHAGES, PERITONEAL; MICE; OSTEOCLASTS; RATS; STAINING AND LABELING;

EID: 0029829704     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Fleisch, H. Bisphosphonates: a new class of drugs in diseases of bone and calcium metabolism. Recent Results Cancer Res. 116:1-28 (1988).
2. Hamdy, N. A. T. Role of bisphosphonates in metabolic bone diseases. Trends Endocrinol. Metab. 4:19-25 (1993).
3. 2MBP-coated bone. Bone Mineral 6:33-43 (1989).
4. Sato, M., and W. Grasser. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J. Bone Miner. Res. 5:31-40 (1990).
5. Sato, M., W. Grasser, N. Endo, R. Akins, H. Simmons, D. D. Thompson, E. Golub, and G. A. Rodan. Bisphosphonate action: alendronate localization in rat bone and effects of osteoclast ultrastructure. J. Clin. Invest. 88: 2095-2105 (1991).
6. +-ATPases differ in their catalytic parameters and sensitivity to tiludronate [Abstract]. Mol. Biol. Cell 5(Suppl.):190a (1994).
7. Selander, K., P. Lehenkari, and H. K. Väänänen. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts. Calcif. Tissue Int. 55:368-375 (1994).
8. Van Rooijen, N., and R. van Nieuwmegen. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate: an enzyme-histochemical study. Cell Tissue Res. 238:355-358 (1984).
9. Mönkkönen, J., A. Urtti, P. Paronen, H. A. Elo, and P. Ylitalo. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro. Drug Metab. Dispos. 17:690-693 (1989).
10. Mönkkönen, J., and T. D. Heath. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif. Tissue Int. 53:139-146 (1993).
11. Mönkkönen, J., M. Taskinen, S. O. K. Auriola, and A. Urtti. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J. Drug Target. 2:299-308 (1994).
12. Wyllie, A. H. Cell death: a new classification separating apoptosis from necrosis, in Cell Death in Biology and Pathology (I. D. Bowen and R. A. Lockshin, eds.). Chapman and Hall, London, 9-34 (1981).
13. Kaufmann, S. Induction of endonucleoytic DNA cleavage in human acute myelogenous leukaemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49:5870-5878 (1989).
14. Wärri, A. N., R. L. Huovinen, A. N. Laine, P. M. Martikainen, and P. L. Härkönen. Apoptosis in toremifene-induced growth-inhibition of human breast cancer cells in vivo and in vitro. J. Natl. Cancer Inst. 85:1412-1418 (1993).
15. Olive, P. L., G. Frazer, and J. P. Banáth. Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat. Res. 136:130-136 (1993).
16. Shimizu, S., Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, and Y. Tsujimoto. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (Lond.) 374:811-813 (1995).
17. Miyashita, T., and J. C. Reed. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52:5407-5411 (1992).
18. Wyllie, A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (Lond.) 284:555-556 (1980).
19. Gavrieli, Y., Y. Sherman, and S. A. Fen-Sasson. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501 (1992).
20. 2MBP) on rat macrophage-mediated bone resorption in vitro. J. Clin. Invest. 70:927-933 (1982).
21. Grigoriadis, A. E., Z.-Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch, and E. F. Wagner. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (Wash-ington D. C.) 266:443-448 (1994).
22. Bartlett, G. R. Phorphorus assay in column chromatography. J. Biol. Chem. 234:466-468 (1959).
23. Kameda, T., H. Ishikawa, and T. Tsutsui. Detection and characterization of apoptosis in osteoclasts in vitro. Biochem. Biophys. Res. Commun. 207:753-760 (1995).
24. Inoue, M., R. Suzuki, T. Koide, N. Sakaguchi, Y. Ogihara, and Y. Yabu. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem. Biophys. Res. Commun. 204:898-904 (1994).
25. Endresen, P. C., T. J. Eide, and J. Aarbakke. Cell death initiated by 3-deazaadenosine in HL-60 cells is apoptosis and is partially inhibited by homocysteine. Biochem. Pharmacol. 46:1893-1901 (1993).
26. Bonfoco, E., S. Ceccatelli, L. Manzo, and P. Nicotera. Colchicine induces apoptosis in cerebellar granule cells. Exp. Cell Res. 218:189-200 (1995).
27. Minkin, C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34:285-290 (1982).
28. Miyashita, T., and J. C. Reed. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-157 (1993).
29. Prytz, P. S., B. E. Band, P. C. Endresen, C. Moeller, and J. Aarbakke. Elevation of cyclic AMP levels in HL-60 cells accumulated in G1 or G2 by transmethylation inhibitors. Biochem. Pharmacol. 42:1761-1766 (1991).
30. McDonnell, T. J., N. Deane, F. M. Platt, G. Nunez, U. Jaeger, J. P. McKearn, and S. J. Korsmeyer, bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79-88 (1989).
31. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967 (1993).
32. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nuñez, and G. Thompson, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608 (1993).
33. C-SCT tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J. Clin. Invest. 91:2791-2795 (1993).
34. Murrills, R. J., L. S. Stein, W. R. Herbert, and D. W. Dempster. Effects of phorbol myristate acetate on rat and chick osteoclasts. J. Bone Miner. Res. 7:415-423 (1992).
35. Qjeda, F., M. I. Guarda, C. Maldonado, and H. Folch. Protein kinase-C involvement in thymocyte apoptosis induced by hydrocortisone. Cell. Immunol. 125:535-542 (1990).
36. Forbes, I. J., P. D. Zalewski, C. Giannakis, and P. A. Cowled. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198:367-374 (1992).
37. Martin, S. J., and T. J. Cotter. Apoptosis in human leukemia: induction, morphology and molecular mechanisms, in Apoptosis II: The Molecular Basis of Apoptosis in Disease (L. Tomei and F. O. Cope, eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1994).
38. Jarvis, T. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelolytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707-1714 (1994).
39. Martin, S. J., and T. G. Cotter. Disruption of microtubules induces an endogenous suicide pathway in human leukemia HL-60 cells. Cell Tissue Kinet. 23:545-549 (1990).
40. Zhang, D., N. Udagawa, I. Nakamura, H. Murakami, S. Saito, K. Yamasaki, Y. Shibasaki, N. Morii, S. Narumiya, N. Takahashi, and T. Suda. The small GTP-binding protein, rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J. Cell Sci. 108:285-229 (1995).
41. Rogers, M. J., R. G. G. Russell, G. M. Blackburn, M. P. Williamson, and D. J. Watts. Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum. Biochem. Biophys. Res. Commun. 189: 414-423 (1992).
42. Schulze-Osthoff, K., H. Walczak, W. Drvge, and P. H. Krammer. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127:15-20 (1994).
43. Selvakumaran, M., H.-K. Lin, T. Miyashita, H. G. Wang, S. Krajewksi, J. Reed, B. Hoffman, and D. Liebermann. Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798 (1994).
44. Emoto, Y., Y. Manome, G. Meinhardt, H. Kisaki, S. Kharbanda, M. Robertson, T. Ghayur, W. W. Wong, R. Kamen, R. Weichselbaum, and D. Kufe. Proteolytic activation of protein kinase C by an ICE-like protease in apoptotic cells. EMBO 14:148-6156 (1995).
45. +-ATPase type in the ruffled borders of osteoclasts. J. Cell Biol. 111:1305-1311 (1990).
46. Sahni, M., H. L. Guenther, H. Fleisch, P. Collin, and T. J. Martin. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J. Clin. Invest. 91:2002-2011 (1993).